Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

February 24, 2022 07:00 ET | Source: ARYA Sciences Acquisition Corp IV

ARYA Sciences Acquisition Corp IV and Amicus Therapeutics, Inc. Mutually Agree to Terminate Business Combination Agreement With Respect to the Acquisition of Amicus’ Gene Therapy Business Due to Market Conditions

NEW YORK, Feb. 24, 2022 (GLOBE NEWSWIRE) -- ARYA Sciences Acquisition Corp IV (NASDAQ: ARYD) (“ARYA IV”), a publicly traded special purpose acquisition company sponsored by Perceptive Advisors...
February 25, 2021 20:04 ET | Source: ARYA Sciences Acquisition Corp IV

ARYA Sciences Acquisition Corp IV Announces Pricing of $130 Million Initial Public Offering

NEW YORK, Feb. 25, 2021 (GLOBE NEWSWIRE) -- ARYA Sciences Acquisition Corp IV (the “Company”), a special purpose acquisition company formed for the purpose of entering into a combination with one or...